MELAUTIM

In MelAutim we are committed to use the project as an opportunity to train, support and promote our junior researchers... In MelAutim our aim is to improve our understanding of the molecular and cellular mechanisms underlying the interplay between autoimmunity and cancer immunotherapy. To this end, we profile patient samples with cutting-edge technologies for molecular profiling like DNA/RNA-Seq, transcriptomics and proteomics... To make possible the understanding of the data, in MelAutim we utilize computational modelling and artificial intelligence to reconstruct and simulate the molecular and cellular networks behind the CPIs-induced autoimmunity. Our aim is to detect molecular signatures characterizing distinct groups of patients suffering the side effects.